An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia

NCT01245530 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Type Dementia

Interventions

DRUG: Aricept
DRUG: INM-176

Sponsor

Whanin Pharmaceutical Company